Hexavalent chromium in tattoo inks: Dermal exposure and systemic risk

Area of Science:

• Environmental Chemistry
• Toxicology
• Public Health

Background:

• Hexavalent chromium (Cr[VI]) is a known human carcinogen and dermal sensitizer.
• European Resolution ResAP(2008)1 limits Cr(VI) in tattoo inks to 0.2 mg/kg.
• Tattoo inks may pose health risks due to Cr(VI) contamination.

Purpose of the Study:

• To quantify Cr(VI) levels in 29 tattoo inks from Europe and the US.
• To assess tattoo ink conformity with European safety standards (ResAP(2008)1).
• To characterize potential dermal and systemic health risks associated with Cr(VI) exposure from tattoo inks.

Main Methods:

• Analysis of Cr(VI) levels using ion chromatography and inductively coupled plasma mass spectrometry.
• Risk assessment through calculation of systemic exposure dosage (SED) and margin of safety (MoS).

Main Results:

• 90% of analyzed tattoo inks exceeded the 0.2 mg/kg Cr(VI) limit, with levels ranging from 0.22-4.09 mg/kg.
• No Cr(VI) information was provided on product labels.
• 27.6% of inks contained over 1 mg/kg Cr(VI), potentially causing dermal reactions.
• Calculated SED values were negligible, and MoS values exceeded 100, indicating no significant systemic risk.

Conclusions:

• Minimizing Cr(VI) contamination in tattoo inks is crucial for enhancing consumer safety.
• Adherence to good manufacturing practices is recommended to ensure tattoo ink safety.
• Further research into manufacturing processes can help reduce Cr(VI) impurities.